Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Saw palmetto causes allergic reaction, minoxidil causes skin irritation; use cautiously for hair loss.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Effective treatments for severe alopecia areata are still lacking.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Syphilitic alopecia, linked to syphilis and high-risk sexual behavior, improves with penicillin treatment.

Some skin diseases and their treatments can negatively affect male fertility.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

The document concludes that syphilis has varied symptoms that are often missed, making clinical awareness crucial for diagnosis.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Rac1 is essential for proper hair structure and color.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

PDCD4 is important for controlling skin cell growth and healing.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Isotretinoin at a low dose for three months does not significantly affect hair growth.

Helmet-like device safely increases hair density for people with hair loss.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.